vs
Assertio Holdings, Inc.（ASRT）与美国合众银行（SFBC）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是美国合众银行的1.4倍（$13.5M vs $9.5M），美国合众银行同比增速更快（1.5% vs -57.9%），过去两年美国合众银行的营收复合增速更高（5.5% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
美国合众银行是一家美国跨国银行机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营银行、投资、抵押贷款等相关金融服务。
ASRT vs SFBC — 直观对比
营收规模更大
ASRT
是对方的1.4倍
$9.5M
营收增速更快
SFBC
高出59.4%
-57.9%
两年增速更快
SFBC
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.5M |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 27.1% |
| 净利率 | — | — |
| 营收同比 | -57.9% | 1.5% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-4.54 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTSFBC
| Q4 25 | $13.5M | $9.5M | ||
| Q3 25 | $49.5M | $9.8M | ||
| Q2 25 | $29.2M | $10.4M | ||
| Q1 25 | $26.5M | $9.2M | ||
| Q4 24 | $32.2M | $9.4M | ||
| Q3 24 | $29.2M | $9.1M | ||
| Q2 24 | $31.1M | $8.6M | ||
| Q1 24 | $32.4M | $8.6M |
净利润ASRTSFBC
| Q4 25 | — | — | ||
| Q3 25 | $11.4M | $1.7M | ||
| Q2 25 | $-16.4M | $2.1M | ||
| Q1 25 | $-13.5M | $1.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | $1.2M | ||
| Q2 24 | $-3.7M | $795.0K | ||
| Q1 24 | $-4.5M | $770.0K |
营业利润率ASRTSFBC
| Q4 25 | -86.7% | 27.1% | ||
| Q3 25 | 23.2% | 21.3% | ||
| Q2 25 | -27.5% | 24.5% | ||
| Q1 25 | -50.0% | 15.9% | ||
| Q4 24 | -41.9% | 24.6% | ||
| Q3 24 | -10.4% | 15.6% | ||
| Q2 24 | -11.6% | 11.4% | ||
| Q1 24 | -13.4% | 10.9% |
净利率ASRTSFBC
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | 17.3% | ||
| Q2 25 | -56.0% | 19.8% | ||
| Q1 25 | -51.1% | 12.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | 12.7% | ||
| Q2 24 | -11.8% | 9.2% | ||
| Q1 24 | -13.9% | 9.0% |
每股收益（稀释后）ASRTSFBC
| Q4 25 | $-4.54 | $0.87 | ||
| Q3 25 | $0.11 | $0.66 | ||
| Q2 25 | $-0.17 | $0.79 | ||
| Q1 25 | $-0.14 | $0.45 | ||
| Q4 24 | $-3.28 | $0.74 | ||
| Q3 24 | $-0.03 | $0.45 | ||
| Q2 24 | $-0.04 | $0.31 | ||
| Q1 24 | $-0.05 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $138.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $109.4M |
| 总资产 | $267.0M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTSFBC
| Q4 25 | $63.4M | $138.5M | ||
| Q3 25 | $93.4M | $101.2M | ||
| Q2 25 | $98.2M | $102.5M | ||
| Q1 25 | $87.3M | $131.5M | ||
| Q4 24 | $100.1M | $43.6M | ||
| Q3 24 | $88.6M | $148.9M | ||
| Q2 24 | $88.4M | $135.1M | ||
| Q1 24 | $80.7M | $138.0M |
总债务ASRTSFBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTSFBC
| Q4 25 | $94.0M | $109.4M | ||
| Q3 25 | $105.8M | $107.5M | ||
| Q2 25 | $93.3M | $106.0M | ||
| Q1 25 | $108.5M | $104.4M | ||
| Q4 24 | $121.1M | $103.7M | ||
| Q3 24 | $130.5M | $102.2M | ||
| Q2 24 | $132.2M | $101.3M | ||
| Q1 24 | $134.5M | $101.0M |
总资产ASRTSFBC
| Q4 25 | $267.0M | $1.1B | ||
| Q3 25 | $319.8M | $1.1B | ||
| Q2 25 | $273.8M | $1.1B | ||
| Q1 25 | $286.4M | $1.1B | ||
| Q4 24 | $284.7M | $993.6M | ||
| Q3 24 | $276.0M | $1.1B | ||
| Q2 24 | $279.4M | $1.1B | ||
| Q1 24 | $282.0M | $1.1B |
负债/权益比ASRTSFBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $7.2M |
| 自由现金流经营现金流 - 资本支出 | — | $7.0M |
| 自由现金流率自由现金流/营收 | — | 73.4% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $12.0M |
8季度趋势，按日历期对齐
经营现金流ASRTSFBC
| Q4 25 | $-30.0M | $7.2M | ||
| Q3 25 | $-4.8M | $3.8M | ||
| Q2 25 | $19.1M | $-494.0K | ||
| Q1 25 | $-12.5M | $1.9M | ||
| Q4 24 | $11.5M | $2.9M | ||
| Q3 24 | $-35.0K | $3.3M | ||
| Q2 24 | $7.4M | $-4.0M | ||
| Q1 24 | $7.5M | $3.5M |
自由现金流ASRTSFBC
| Q4 25 | — | $7.0M | ||
| Q3 25 | — | $3.8M | ||
| Q2 25 | — | $-518.0K | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $1.9M |
自由现金流率ASRTSFBC
| Q4 25 | — | 73.4% | ||
| Q3 25 | — | 38.3% | ||
| Q2 25 | — | -5.0% | ||
| Q1 25 | — | 19.8% | ||
| Q4 24 | — | 30.4% | ||
| Q3 24 | — | 35.5% | ||
| Q2 24 | — | -65.4% | ||
| Q1 24 | — | 22.2% |
资本支出强度ASRTSFBC
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | — | 19.0% |
现金转化率ASRTSFBC
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 2.24× | ||
| Q2 25 | — | -0.24× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.84× | ||
| Q2 24 | — | -5.05× | ||
| Q1 24 | — | 4.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
SFBC
暂无分部数据
